[Results of clinical testing of carbochromen in chronic coronary insufficiency].
D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001015:Aortic Arch Syndromes / Q000188:drug therapy*; D001775:Blood Circulation / Q000187:drug effects; D001810:Blood Volume / Q000187:drug effects; D002301:Cardiac Glycosides / Q000627:therapeutic use; D002306:Cardiac Volume / Q000187:drug effects; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy*; D003864:Depression, Chemical; D004562:Electrocardiography; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D010437:Peptic Ulcer / Q000188:drug therapy*; D010919:Placebos; D011433:Propranolol / Q000627:therapeutic use*; D011652:Pulmonary Circulation / Q000187:drug effects; D013128:Spinal Osteophytosis / Q000188:drug therapy*; D013268:Stimulation, Chemical; D014149:Tranquilizing Agents / Q000627:therapeutic use; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D014717:Vertigo / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D000959:Antihypertensive Agents; D002301:Cardiac Glycosides; D010919:Placebos; D014149:Tranquilizing Agents; D014665:Vasodilator Agents; D011433:Propranolol
Ergebnisse der klinischen Prüfung von Carbochromen bei chronischer Coronarinsuffizienz.